Mutual antagonism between IP3RII and miRNA-133a regulates calcium signals and cardiac hypertrophy

Journal of Cell Biology

Volumn 199, Issue 5, 2012, Pages 783-798

  Drawnel, Faye M ^a   Wachten, Dagmar ^a,b   Molkentin, Jeffery D ^c   Maillet, Marjorie ^c   Aronsen, Jan Magnus ^d,e   Swift, Fredrik ^d   Sjaastad, Ivar ^d   Liu, Ning ^f   Catalucci, Daniele ^g,h   Mikoshiba, Katsuhiko ⁱ   Hisatsune, Chihiro ⁱ   Okkenhaug, Hanneke ^a   Andrews, Simon R ^a   Bootman, Martin D ^a   Roderick, H Llewelyn ^a,j  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b CENTER OF ADVANCED EUROPEAN STUDIES AND RESEARCH CAESAR   (Germany)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e BJØRKNES UNIVERSITY COLLEGE   (Norway)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^h Milan Unit   (Italy)

ⁱ RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^j UNIVERSITY OF CAMBRIDGE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; INOSITOL 1,4,5' TRIPHOSPHATE RECEPTOR II; MICRORNA; MICRORNA 133A; NEUROHORMONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONTROLLED STUDY; DOWN REGULATION; HEART LEFT VENTRICLE OVERLOAD; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CALCIUM SIGNALING; CARDIOMEGALY; CELLS, CULTURED; HEK293 CELLS; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MICRORNAS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, WISTAR;

EID: 84872001045     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201111095     Document Type: Article

References (54)

1. Bartel, D.P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116:281-297. http://dx.doi.org/10.1016/S0092-8674(04)00045-5
2. Bartel, D.P., and C.Z. Chen. 2004. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat. Rev. Genet. 5:396-400. http://dx.doi.org/10.1038/nrg1328
3. Belaguli, N.S., W. Zhou, T.H. Trinh, M.W. Majesky, and R.J. Schwartz. 1999. Dominant negative murine serum response factor: alternative splicing within the activation domain inhibits transactivation of serum response factor binding targets. Mol. Cell. Biol. 19:4582-4591.
4. Berridge, M.J., M.D. Bootman, and H.L. Roderick. 2003. Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 4:517-529. http://dx.doi.org/10.1038/nrm1155
5. Brattelid, T., E. Qvigstad, J.A. Birkeland, F. Swift, S.V. Bekkevold, K.A. Krobert, O.M. Sejersted, T. Skomedal, J.B. Osnes, F.O. Levy, and I. Sjaastad. 2007. Serotonin responsiveness through 5-HT2A and 5-HT4 receptors is differentially regulated in hypertrophic and failing rat cardiac ventricle. J. Mol. Cell. Cardiol. 43:767-779. http://dx.doi.org/10.1016/j.yjmcc.2007.08.019
6. Cao, D.J., Z.V. Wang, P.K. Battiprolu, N. Jiang, C.R. Morales, Y. Kong, B.A. Rothermel, T.G. Gillette, and J.A. Hill. 2011. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc. Natl. Acad. Sci. USA. 108:4123-4128. http://dx.doi.org/10.1073/pnas.1015081108
7. Carè, A., D. Catalucci, F. Felicetti, D. Bonci, A. Addario, P. Gallo, M.L. Bang, P. Segnalini, Y. Gu, N.D. Dalton, et al. 2007. MicroRNA-133 controls cardiac hypertrophy. Nat. Med. 13:613-618. http://dx.doi.org/10.1038/nm1582
8. Choi, W.-Y., A.J. Giraldez, and A.F. Schier. 2007. Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430. Science. 318:271-274. http://dx.doi.org/10.1126/science.1147535
9. Da Costa Martins, P.A., K. Salic, M.M. Gladka, A.-S. Armand, S. Leptidis, H. el Azzouzi, A. Hansen, C.J. Coenen-de Roo, M.F. Bierhuizen, R. van der Nagel, et al. 2010. MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat. Cell Biol. 12:1220-1227. http://dx.doi.org/10.1038/ncb2126
10. Dillmann, W.H. 2008. The rat as a model for cardiovascular disease. Drug Discov. Today Dis. Models. 5:173-178. http://dx.doi.org/10.1016/j.ddmod.2009.03.006
11. Dong, D.L., C. Chen, R. Huo, N. Wang, Z. Li, Y.J. Tu, J.T. Hu, X. Chu, W. Huang, and B.F. Yang. 2010. Reciprocal repression between microRNA- 133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy. Hypertension. 55:946-952. http://dx.doi.org/10.1161/HYPERTENSIONAHA.109.139519
12. Dorn, G.W. II. 2007. The fuzzy logic of physiological cardiac hypertrophy. Hypertension. 49:962-970. http://dx.doi.org/10.1161/HYPERTENSIONAHA.106.079426
13. Drawnel, F.M., C.R. Archer, and H.L. Roderick. 2012. The role of the paracrine/ autocrine mediator endothelin-1 in regulation of cardiac contractility and growth. Br. J. Pharmacol.
14. Elia, L., R. Contu, M. Quintavalle, F. Varrone, C. Chimenti, M.A. Russo, V. Cimino, L. De Marinis, A. Frustaci, D. Catalucci, and G. Condorelli. 2009. Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation. 120:2377-2385. http://dx.doi.org/10.1161/CIRCULATIONAHA.109.879429
15. Futatsugi, A., T. Nakamura, M.K. Yamada, E. Ebisui, K. Nakamura, K. Uchida, T. Kitaguchi, H. Takahashi-Iwanaga, T. Noda, J. Aruga, and K. Mikoshiba. 2005. IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. Science. 309:2232-2234. http://dx.doi.org/10.1126/science.1114110
16. Guatimosim, S., M.J. Amaya, M.T. Guerra, C.J. Aguiar, A.M. Goes, N.L. Gómez- Viquez, M.A. Rodrigues, D.A. Gomes, J. Martins-Cruz, W.J. Lederer, and M.F. Leite. 2008. Nuclear Ca2+ regulates cardiomyocyte function. Cell Calcium. 44:230-242. http://dx.doi.org/10.1016/j.ceca.2007.11.016
17. Guo, A., S.E. Cala, and L.S. Song. 2012. Calsequestrin accumulation in rough endoplasmic reticulum promotes perinuclear Ca2+ release. J. Biol. Chem. 287:16670-16680. http://dx.doi.org/10.1074/jbc.M112.340927
18. Haider, A.W., M.G. Larson, E.J. Benjamin, and D. Levy. 1998. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J. Am. Coll. Cardiol. 32:1454-1459. http://dx.doi.org/10.1016/S0735-1097(98)00407-0
19. Harzheim, D., M. Movassagh, R.S. Foo, O. Ritter, A. Tashfeen, S.J. Conway, M.D. Bootman, and H.L. Roderick. 2009. Increased InsP3Rs in the junctional sarcoplasmic reticulum augment Ca2+ transients and arrhythmias associated with cardiac hypertrophy. Proc. Natl. Acad. Sci. USA. 106:11406-11411. http://dx.doi.org/10.1073/pnas.0905485106
20. Harzheim, D., A. Talasila, M. Movassagh, R.S. Foo, N. Figg, M.D. Bootman, and H.L. Roderick. 2010. Elevated InsP3R expression underlies enhanced calcium fluxes and spontaneous extra-systolic calcium release events in hypertrophic cardiac myocytes. Channels (Austin). 4:67-71. http://dx.doi.org/10.4161/chan.4.1.10531
21. Higazi, D.R., C.J. Fearnley, F.M. Drawnel, A. Talasila, E.M. Corps, O. Ritter, F. McDonald, K. Mikoshiba, M.D. Bootman, and H.L. Roderick. 2009. Endothelin-1-stimulated InsP3-induced Ca2+ release is a nexus for hypertrophic signaling in cardiac myocytes. Mol. Cell. 33:472-482. http://dx.doi.org/10.1016/j.molcel.2009.02.005
22. Hill, J.A., M. Karimi, W. Kutschke, R.L. Davisson, K. Zimmerman, Z. Wang, R.E. Kerber, and R.M. Weiss. 2000. Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. Circulation. 101:2863-2869. http://dx.doi.org/10.1161/01.CIR.101.24.2863
23. Ikeda, S., S.W. Kong, J. Lu, E. Bisping, H. Zhang, P.D. Allen, T.R. Golub, B. Pieske, and W.T. Pu. 2007. Altered microRNA expression in human heart disease. Physiol. Genomics. 31:367-373. http://dx.doi.org/10.1152/physiolgenomics.00144.2007
24. Kjeldsen, S.E., B. Dahlöf, R.B. Devereux, S. Julius, P. Aurup, J. Edelman, G. Beevers, U. de Faire, F. Fyhrquist, H. Ibsen, et al. 2002. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. JAMA. 288:1491-1498. http://dx.doi.org/10.1001/jama.288.12.1491
25. Kook, H., J.J. Lepore, A.D. Gitler, M.M. Lu, W. Wing-Man Yung, J. Mackay, R. Zhou, V. Ferrari, P. Gruber, and J.A. Epstein. 2003. Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. J. Clin. Invest. 112:863-871.
26. Li, Q., X. Lin, X. Yang, and J. Chang. 2010a. NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression. Am. J. Physiol. Heart Circ. Physiol. 298:H1340-H1347. http://dx.doi.org/10.1152/ajpheart.00592.2009
27. Li, Q., X.-W. Song, J. Zou, G.-K. Wang, E. Kremneva, X.-Q. Li, N. Zhu, T. Sun, P. Lappalainen, W.-J. Yuan, et al. 2010b. Attenuation of microRNA-1 derepresses the cytoskeleton regulatory protein twinfilin-1 to provoke cardiac hypertrophy. J. Cell Sci. 123:2444-2452. http://dx.doi.org/10.1242/jcs.067165
28. Lim, L.P., N.C. Lau, P. Garrett-Engele, A. Grimson, J.M. Schelter, J. Castle, D.P. Bartel, P.S. Linsley, and J.M. Johnson. 2005. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 433:769-773. http://dx.doi.org/10.1038/nature03315
29. Lipp, P., M. Laine, S.C. Tovey, K.M. Burrell, M.J. Berridge, W. Li, and M.D. Bootman. 2000. Functional InsP3 receptors that may modulate excitationcontraction coupling in the heart. Curr. Biol. 10:939-942. http://dx.doi.org/10.1016/S0960-9822(00)00624-2
30. Liu, N., A.H. Williams, Y. Kim, J. McAnally, S. Bezprozvannaya, L.B. Sutherland, J.A. Richardson, R. Bassel-Duby, and E.N. Olson. 2007. An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. Proc. Natl. Acad. Sci. USA. 104:20844-20849. http://dx.doi.org/10.1073/pnas.0710558105
31. Liu, N., S. Bezprozvannaya, A.H. Williams, X. Qi, J.A. Richardson, R. Bassel- Duby, and E.N. Olson. 2008. microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev. 22:3242-3254. http://dx.doi.org/10.1101/gad.1738708
32. Luo, D., D. Yang, X. Lan, K. Li, X. Li, J. Chen, Y. Zhang, R.P. Xiao, Q. Han, and H. Cheng. 2008. Nuclear Ca2+ sparks and waves mediated by inositol 1,4,5-trisphosphate receptors in neonatal rat cardiomyocytes. Cell Calcium. 43:165-174. http://dx.doi.org/10.1016/j.ceca.2007.04.017
33. Luo, J., Z.L. Deng, X. Luo, N. Tang, W.X. Song, J. Chen, K.A. Sharff, H.H. Luu, R.C. Haydon, K.W. Kinzler, et al. 2007. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat. Protoc. 2:1236-1247. http://dx.doi.org/10.1038/nprot.2007.135
34. Matkovich, S.J., W. Wang, Y. Tu, W.H. Eschenbacher, L.E. Dorn, G. Condorelli, A. Diwan, J.M. Nerbonne, and G.W. Dorn II. 2010. MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressureoverloaded adult hearts. Circ. Res. 106:166-175. http://dx.doi.org/10.1161/CIRCRESAHA.109.202176
35. Matkovich, S.J., D.J. Van Booven, W.H. Eschenbacher, and G.W. Dorn II. 2011. RISC RNA sequencing for context-specific identification of in vivo microRNA targets. Circ. Res. 108:18-26. http://dx.doi.org/10.1161/CIRCRESAHA.110.233528
36. Nakayama, H., B.J. Wilkin, I. Bodi, and J.D. Molkentin. 2006. Calcineurindependent cardiomyopathy is activated by TRPC in the adult mouse heart. FASEB J. 20:1660-1670. http://dx.doi.org/10.1096/fj.05-5560com
37. Nakayama, H., I. Bodi, M. Maillet, J. DeSantiago, T.L. Domeier, K. Mikoshiba, J.N. Lorenz, L.A. Blatter, D.M. Bers, and J.D. Molkentin. 2010. The IP3 receptor regulates cardiac hypertrophy in response to select stimuli. Circ. Res. 107:659-666. http://dx.doi.org/10.1161/CIRCRESAHA.110.220038
38. Niu, Z., A. Li, S.X. Zhang, and R.J. Schwartz. 2007. Serum response factor micromanaging cardiogenesis. Curr. Opin. Cell Biol. 19:618-627. http://dx.doi.org/10.1016/j.ceb.2007.09.013
39. Perez, P.J., J. Ramos-Franco, M. Fill, and G.A. Mignery. 1997. Identification and functional reconstitution of the type 2 inositol 1,4,5-trisphosphate receptor from ventricular cardiac myocytes. J. Biol. Chem. 272:23961-23969. http://dx.doi.org/10.1074/jbc.272.38.23961
40. Posern, G., and R. Treisman. 2006. Actin' together: serum response factor, its cofactors and the link to signal transduction. Trends Cell Biol. 16:588-596. http://dx.doi.org/10.1016/j.tcb.2006.09.008
41. Rinne, A., and L.A. Blatter. 2010. Activation of NFATc1 is directly mediated by IP3 in adult cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 299:H1701-H1707. http://dx.doi.org/10.1152/ajpheart.00470.2010
42. Sanbe, A., J. Gulick, M.C. Hanks, Q. Liang, H. Osinska, and J. Robbins. 2003. Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter. Circ. Res. 92:609-616. http://dx.doi.org/10.1161/01.RES.0000065442.64694.9F
43. Sayed, D., C. Hong, I.-Y. Chen, J. Lypowy, and M. Abdellatif. 2007. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ. Res. 100:416-424. http://dx.doi.org/10.1161/01.RES.0000257913.42552.23
44. Small, E.M., and E.N. Olson. 2011. Pervasive roles of microRNAs in cardiovascular biology. Nature. 469:336-342. http://dx.doi.org/10.1038/nature09783
45. Thum, T., D. Catalucci, and J. Bauersachs. 2008. MicroRNAs: novel regulators in cardiac development and disease. Cardiovasc. Res. 79:562-570. http://dx.doi.org/10.1093/cvr/cvn137
46. Tovey, S.C., P. de Smet, P. Lipp, D. Thomas, K.W. Young, L. Missiaen, H. De Smedt, J.B. Parys, M.J. Berridge, J. Thuring, et al. 2001. Calcium puffs are generic InsP(3)-activated elementary calcium signals and are downregulated by prolonged hormonal stimulation to inhibit cellular calcium responses. J. Cell Sci. 114:3979-3989.
47. Uchiyama, T., F. Yoshikawa, A. Hishida, T. Furuichi, and K. Mikoshiba. 2002. A novel recombinant hyperaffinity inositol 1,4,5-trisphosphate (IP(3)) absorbent traps IP(3), resulting in specific inhibition of IP(3)-mediated calcium signaling. J. Biol. Chem. 277:8106-8113. http://dx.doi.org/10.1074/jbc.M108337200
48. van Rooij, E., L.B. Sutherland, N. Liu, A.H. Williams, J. McAnally, R.D. Gerard, J.A. Richardson, and E.N. Olson. 2006. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl. Acad. Sci. USA. 103:18255-18260. http://dx.doi.org/10.1073/pnas.0608791103
49. van Rooij, E., L.B. Sutherland, X. Qi, J.A. Richardson, J. Hill, and E.N. Olson. 2007. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science. 316:575-579. http://dx.doi.org/10.1126/science.1139089
50. Vandesompele, J., K. De Preter, F. Pattyn, B. Poppe, N. Van Roy, A. De Paepe, and F. Speleman. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3:H0034-h0034.11. http://dx.doi.org/10.1186/gb-2002-3-7-research0034
51. Wang, Z., D.-Z. Wang, D. Hockemeyer, J. McAnally, A. Nordheim, and E.N. Olson. 2004. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature. 428:185-189. http://dx.doi.org/10.1038/nature02382
52. Wu, X., T. Zhang, J. Bossuyt, X. Li, T.A. McKinsey, J.R. Dedman, E.N. Olson, J. Chen, J.H. Brown, and D.M. Bers. 2006. Local InsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitation-transcription coupling. J. Clin. Invest. 116:675-682. http://dx.doi.org/10.1172/JCI27374
53. Zhang, X., G. Azhar, S.A. Helms, and J.Y. Wei. 2011. Regulation of cardiac microRNAs by serum response factor. J. Biomed. Sci. 18:15. http://dx.doi.org/10.1186/1423-0127-18-15
54. Zhao, Y., E. Samal, and D. Srivastava. 2005. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature. 436:214-220. http://dx.doi.org/10.1038/nature03817